CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 111 enrolled / 111 target
Drug / intervention
Dexmedetomidine injection +2 moredrug
Likely dose
Dexmedetomidine injection 0.5 mcg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06304909
NCT06304909Phase 1CompletedHigh Momentum (4.3/mo)Completion was 15mo ago
CompareCT.gov

Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block

Assiut University·interventional·Posted Mar 12, 2024·Updated Jun 24, 2026

In Brief

A Phase 1 clinical trial evaluating Dexmedetomidine injection, Dexamethasone, and 1 other intervention for Trauma Injury. Completed, enrolled 111 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

Effect of intravenous dexmedetomidine versus dexamethasone for management of repound pain after supraclavicular brachial plexus block.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTrauma Injury
CountriesEgypt
Collaborators--

Timeline

Phase 1CompletedFinished
20252026
First PostedMar 12, 2024
Enrollment StartMay 15, 2024
Primary CompletionMar 10, 2025
Study CompletionMar 20, 2025
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.3 years ago

Arms & Interventions

Dexmedetomidine group will receive 0.5 mcg/kgexperimental

Drug: Dexmedetomidine injection
Dexamethasone group will receive 8mg/kgexperimental

Drug: Dexamethasone
Control group will receive equivalent volume of saline 0.9%.experimental

Drug: Saline

Interventions

Dexmedetomidine injectiondrug

Dexmedetomidine group will receive 0.5 mcg/kg

Dexamethasonedrug

Dexamethasone group will receive 8mg/kg

Salinedrug

receive equivalent volume of saline 0.9%.